CENTOCOR's MYOSCINT RECOMMENDED FOR APPROVAL AS FIRST MONOCLONAL IMAGING AGENT FOR USE IN DETECTION OF TISSUE DEATH FOLLOWING MYOCARDIAL INFARCTION

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".